C

Centennial Medical Group | Elkridge, MD

Research site
(Unclaimed)
Location
8186 Lark Brown Road, Elkridge, Maryland, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

9 of 44
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight

This study will look at how a new medicine called NNC0519-0130 helps people with excess body weight lose weight. The study will test up to 6 differen...

Not yet enrolling
Obesity
Drug: NNC0519-0130
Drug: Tirzepatide

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide

The purpose of this study is to evaluate the safety and immunogenicity in parallel of heptavalent mRNA-1975 and monovalent mRNA-1982 against Lyme dis...

Active, not recruiting
Lyme Disease
Biological: mRNA-1975
Biological: Placebo
Locations recently updated

The purpose of this clinical study is to learn about the safety, extent of the side effects (reaction to vaccine), and immune response (your immune s...

Enrolling
Shingles
Human
Biological: Selected Vaccine Candidate group (Dose level, Schedule)
Biological: Shingrix - SSB

The purpose of this clinical trial is to learn about a pneumococcal vaccine with a new ingredient (PF-07872411) intended to enhance the effects of th...

Active, not recruiting
Pneumococcal Disease
Biological: Standard dose multivalent pneumococcal conjugate vaccine control
Biological: Low dose of multivalent pneumococcal conjugate vaccine control

The primary objective of this study is to assess the effect of enobosarm on total lean mass as measured by DEXA in patients maintained on GLP-1 recep...

Begins enrollment this month
Obesity
Muscle Loss
Drug: Semaglutide
Drug: Enobosarm

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Ob...

Enrolling
OSA
Drug: Placebo
Drug: AD109

The purpose or AROAPOC3-3001 is to evaluate the efficacy and safety of ARO-APOC3 in adult participants with familial chylomicronemia syndrome (FCS)....

Active, not recruiting
Familial Chylomicronemia
Drug: Placebo
Drug: ARO-APOC3

This is a Phase 3, randomized, parallel-group, comparator-controlled, observer-blind, multicenter study of immunogenicity and safety in approximately...

Active, not recruiting
Influenza, Human
Biological: licensed QIV1
Biological: licensed QIV2

Trial conditions

Colorectal Cancer (7 trials)
Diabetes Mellitus (4 trials)
Human Influenza (4 trials)
Obesity (4 trials)
Type 2 Diabetes Mellitus (4 trials)
COVID-19 (3 trials)
Overweight (3 trials)
Pneumococcal Infections (3 trials)
Dyslipidemias (2 trials)
Hypogonadism (2 trials)

And 24 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems